Get news updates from AACRMeetingNews.org
Subscribe below to get email updates from AACRMeetingNews.org
NCI Acting Director Douglas R. Lowy, MD, FAACR, chaired an Annual Meeting symposium that provided an update on clinical vaccine research efforts designed to prevent HPV, pancreatic cancer, and Lynch syndrome. Read more
During the final session of the AACR Annual Meeting 2022, Program Committee Chair Marcia R. Cruz-Correa, MD, PhD, and three members of the Program Committee reviewed several significant highlights and important themes from the meeting. Read more
On the final day of the Annual Meeting, Anna D. Barker, PhD, chaired a plenary session dedicated to tumor evolution. “We are going to see people putting evolution to work in the very near future,” she said. Read more
During a plenary session on Tuesday, April 12, four researchers discussed the latest advances in immuno-oncology, including developments in the understanding of immunotherapy modalities, efficacy, and combination strategies. Carl H. June, MD, FAACR, chaired the session. Read more
The Annual Meeting’s final Clinical Trials Plenary Session featured trials of immunotherapy drug combinations that could benefit patients who don’t respond to single-agent immunotherapy or chemotherapy combinations. Timothy A. Yap, MD, PhD, chaired the session. Read more
Organized by the AACR Chemistry in Cancer Research working group, this year’s three "New Drugs on the Horizon" sessions featured first disclosures of the discovery and structure of 12 novel agents. Read more
Mariana C. Stern, PhD, led a plenary session featuring cancer researchers from around the world who discussed the integration of complex data and diversity to achieve better health equity. Read more
Outgoing AACR President David A. Tuveson, MD, PhD, FAACR, discussed the unique challenges in the fight against pancreatic cancer and what it will take to achieve the aggressive targets of the Cancer Moonshot initiative in this patient population. Read more
The Opening Plenary Session at the AACR Annual Meeting 2022 featured five state-of-the-art scientific presentations and a special lecture on the future of cancer research by Charles L. Sawyers, MD, FAACR. Read more
Catriona H. M. Jamieson, MD, PhD, previews the Precancer Discover Science plenary, which examined new perspectives on cancer prevention, an integral part of the AACR’s research and health policy efforts. Read more
The AACR honored dozens of cancer researchers, physician-scientists, advocates, and policymakers for their achievements during the Annual Meeting. Read more
The Annual Meeting program officially launches today and features 50 Educational Sessions and 13 Methods Workshops covering the hottest cancer research topics, according to Lillian L. Siu, MD, Chair of the Annual Meeting Education Committee. Read more
Among the themes and topics expected to garner a lot of attention this year are trials looking at cellular therapies, novel immunotherapeutics, and molecularly targeted therapy drugs, according to Timothy A. Yap, MD, PhD, and Julie R. Brahmer, MD, MSc. Read more